XML 48 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders Deficit (Tables)
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Summary of Stock Option Plans Activity

A summary of the Company’s stock option activity for the six months ended June 30, 2020 is as follows:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise Price

Per Share

 

 

Weighted-

Average

Remaining

Contractual

Life (Years)

 

 

Aggregate

Intrinsic Value

 

Balance at December 31, 2019

 

 

2,904,898

 

 

$

2.37

 

 

 

8.0

 

 

$

781

 

Granted

 

 

1,347,500

 

 

 

0.69

 

 

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

$

-

 

Forfeited

 

 

(212,860

)

 

 

1.79

 

 

 

 

 

 

 

 

 

Expired/Cancelled

 

 

(48,804

)

 

 

3.42

 

 

 

 

 

 

 

 

 

Balance at June 30, 2020

 

 

3,990,734

 

 

$

1.82

 

 

 

8.1

 

 

$

54,750

 

Exercisable at June 30, 2020

 

 

2,046,557

 

 

$

2.27

 

 

 

7.0

 

 

$

13,038

 

 

Summary of Restricted Stock Unit ("RSU") Award Activity

The following table summarizes restricted stock unit (“RSU”) award activity for the six months ended June 30, 2020:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

Per Share

 

Balance at December 31, 2019

 

 

223,745

 

 

$

2.91

 

Granted

 

 

22,500

 

 

 

0.75

 

Released

 

 

(59,693

)

 

 

2.66

 

Forfeited

 

 

(16,875

)

 

 

3.04

 

Balance at June 30, 2020

 

 

169,677

 

 

$

2.70

 

Vested and unissued at June 30, 2020

 

 

23,126

 

 

$

2.73

 

 

Summary of Stock-Based Compensation Recorded in the Condensed Consolidated Statements of Operations

Stock-based compensation expense recorded in the accompanying condensed consolidated statements of operations for the three and six months ended June 30, 2020 and 2019 was as follows:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Selling, general and administrative

 

$

338,063

 

 

$

217,195

 

 

$

696,075

 

 

$

399,176

 

Research and development

 

 

24,913

 

 

 

58,234

 

 

 

83,418

 

 

 

106,684

 

Cost of product and product-related services revenue

 

 

3,904

 

 

 

11,903

 

 

 

8,058

 

 

 

22,718

 

 

 

$

366,880

 

 

$

287,332

 

 

$

787,551

 

 

$

528,578